Atlas Trials

A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

Clinical trial NCT07149818 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07149818
Sponsor
Peking Union Medical College Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Autoimmune Hemolytic Anemia
Start date
2025-09-01
Primary completion
2027-01-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.